These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29067779)

  • 1. An Antibacterial β-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis.
    Lehmann J; Cheng TY; Aggarwal A; Park AS; Zeiler E; Raju RM; Akopian T; Kandror O; Sacchettini JC; Moody DB; Rubin EJ; Sieber SA
    Angew Chem Int Ed Engl; 2018 Jan; 57(1):348-353. PubMed ID: 29067779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis.
    Wilson R; Kumar P; Parashar V; Vilchèze C; Veyron-Churlet R; Freundlich JS; Barnes SW; Walker JR; Szymonifka MJ; Marchiano E; Shenai S; Colangeli R; Jacobs WR; Neiditch MB; Kremer L; Alland D
    Nat Chem Biol; 2013 Aug; 9(8):499-506. PubMed ID: 23770708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
    Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in
    Kim S; Seo H; Mahmud HA; Islam MI; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
    J Microbiol Biotechnol; 2017 Nov; 27(11):1932-1941. PubMed ID: 28870005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages.
    Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS
    Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32.
    Stanley SA; Kawate T; Iwase N; Shimizu M; Clatworthy AE; Kazyanskaya E; Sacchettini JC; Ioerger TR; Siddiqi NA; Minami S; Aquadro JA; Grant SS; Rubin EJ; Hung DT
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11565-70. PubMed ID: 23798446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial drugs: hitting the tuberculosis wall.
    Harrison C
    Nat Rev Drug Discov; 2013 Aug; 12(8):578-9. PubMed ID: 23903215
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis.
    Thanna S; Knudson SE; Grzegorzewicz A; Kapil S; Goins CM; Ronning DR; Jackson M; Slayden RA; Sucheck SJ
    Org Biomol Chem; 2016 Jul; 14(25):6119-6133. PubMed ID: 27251120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
    Tahlan K; Wilson R; Kastrinsky DB; Arora K; Nair V; Fischer E; Barnes SW; Walker JR; Alland D; Barry CE; Boshoff HI
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1797-809. PubMed ID: 22252828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A piperidinol-containing molecule is active against
    Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
    J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
    Cavalier JF; Spilling CD; Durand T; Camoin L; Canaan S
    Eur J Med Chem; 2021 Jan; 209():112908. PubMed ID: 33071055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biosynthesis of mycolic acids in Mycobacterium tuberculosis relies on multiple specialized elongation complexes interconnected by specific protein-protein interactions.
    Veyron-Churlet R; Bigot S; Guerrini O; Verdoux S; Malaga W; Daffé M; Zerbib D
    J Mol Biol; 2005 Nov; 353(4):847-58. PubMed ID: 16213523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exocarpic acid inhibits mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Koch M; Bugni TS; Sondossi M; Ireland CM; Barrows LR
    Planta Med; 2010 Oct; 76(15):1678-82. PubMed ID: 20506078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.
    Alsayed SSR; Beh CC; Foster NR; Payne AD; Yu Y; Gunosewoyo H
    Curr Mol Pharmacol; 2019; 12(1):27-49. PubMed ID: 30360731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
    Xu W; DeJesus MA; Rücker N; Engelhart CA; Wright MG; Healy C; Lin K; Wang R; Park SW; Ioerger TR; Schnappinger D; Ehrt S
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.
    North EJ; Jackson M; Lee RE
    Curr Pharm Des; 2014; 20(27):4357-78. PubMed ID: 24245756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biosynthesis and regulation of mycolic acids in Mycobacterium tuberculosis--a review].
    Luo H; Pang L; Xie J
    Wei Sheng Wu Xue Bao; 2012 Feb; 52(2):146-51. PubMed ID: 22586991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis.
    Belardinelli JM; Morbidoni HR
    Expert Rev Anti Infect Ther; 2013 Apr; 11(4):429-40. PubMed ID: 23566152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of Mycolic Acid Biosynthesis Genes and Their Regulation during Starvation in Mycobacterium tuberculosis.
    Jamet S; Quentin Y; Coudray C; Texier P; Laval F; Daffé M; Fichant G; Cam K
    J Bacteriol; 2015 Dec; 197(24):3797-811. PubMed ID: 26416833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the mycobacterial envelope for tuberculosis drug development.
    Favrot L; Ronning DR
    Expert Rev Anti Infect Ther; 2012 Sep; 10(9):1023-36. PubMed ID: 23106277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.